Vagus nerve stimulation for the treatment of medically refractory epilepsy—about one third of cases—was pioneered by Cyberonics, Inc., and over 60,000 patients have received implants worldwide. Now, Cerbomed, a private medical device company in Erlangen, Germany, is pursuing a noninvasive approach to treating epilepsy.